Literature DB >> 29150880

A slowly developed severe cutaneous adverse reaction to idelalisib.

L Huilaja1,2, O Lindgren3,4, M Soronen1,2, T Siitonen5, K Tasanen1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29150880     DOI： 10.1111/jdv.14700

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  1 in total

1.  Management of psoriasis-like rash associated with idelalisib monotherapy in a patient with refractory follicular lymphoma: a case report.

Authors:  Salma Machan; Carlos Plaza; Yosmar Pérez-González; Maria Rodriguez-Pinilla; Luis Requena; Raul Cordoba
Journal:  J Med Case Rep       Date:  2020-02-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.